CMS Places Marketing, Enrollment Freeze On Health Net Prescription Drug Plans
Main Category: Health Insurance / Medical InsuranceArticle Date: 22 Feb 2008 - 12:00 PDT
| Patient / Public: | ![]() |
3.67 (3 votes) |
| Health Professional: | ![]() |
|
| Article Opinions: | 0 posts |
CMS has ordered California-based health insurer Health Net to stop marketing and enrollment for its "Health Net Orange" Medicare prescription drug plans, according to a notice on a government Web site, Florida Health News reports. The freeze was enacted because the company failed to process enrollment applications on time and sent members incorrect information about the changes in coverage for 2008, according to CMS spokesperson Allison Henry.
Members of the prescription drug plan who enrolled after Jan. 16, when the marketing and enrollment freeze took effect, will be given the option to switch to another Medicare drug plan, Health Net spokesperson Amy Sheyer said. The company is required by CMS to draft a plan to correct problems. "We're talking with CMS on a regular basis and working through the corrective action process," Sheyer said (Jaffe, Florida Health News, 2/15).
Reprinted with kind permission from http://www.kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation© 2005 Advisory Board Company and Kaiser Family Foundation. All rights reserved.
|
Please rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add to:
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
| Back to top | Back to front page | List of All Medical Articles |
| Privacy Policy | Terms and Conditions | © 2008 MediLexicon International Ltd |






